Recruiting

MuSK MG

Sponsor:

George Washington University

Code:

NCT06259071

Conditions

Myasthenia Gravis

MuSK MG

MuSK Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 7 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The MuSK myasthenia gravis 1000 study seeks to collect saliva samples from 1000 subjects with laboratory confirmed diagnosis of MuSK myasthenia to identify genetic variations associated with MuSK MG. The data collected may be used by researchers to gain a better understanding of the cause of MuSK MG and to identify biomarkers and targeted therapy for MuSK MG.

Conditions

Myasthenia Gravis

MuSK MG

MuSK Myasthenia Gravis

Study ID

NCT06259071

Start date

Aug 23, 2023

Status verified date

Aug, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Aug 23, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 7 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Lab test confirming diagnosis of MuSK myasthenia gravis
  • Willingness to provide saliva sample via mail or in person

Exclusion Criteria:

  • Inability to provide informed consent
  • Unwillingness to provide lab results of elevated muscle specific kinase antibody
  • Unwillingness to provide saliva sample

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • GWAS [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Locations

George Washington University

Recruiting

Washington D.C., District of Columbia, United States, 20037

Contacts

More Information

Sponsor

George Washington University

Last update posted

Aug 5, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by George Washington University on 2026-08-05.